Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Group III mGlu Receptor Agonist, ACPT-I, Exerts Potential Neuroprotective Effects In Vitro and In Vivo
Helena Domin, Krystyna Gołembiowska, Danuta Jantas, et al.
Neurotoxicity Research (2014) Vol. 26, Iss. 1, pp. 99-113
Open Access | Times Cited: 20

Showing 20 citing articles:

Role of Metabotropic Glutamate Receptors in Neurological Disorders
Rosalia Crupi, Daniela Impellizzeri, Salvatore Cuzzocrea
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 210
Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease
Kenneth Maiese
Neural Regeneration Research (2015) Vol. 10, Iss. 4, pp. 518-518
Open Access | Times Cited: 71
International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors
Karen J. Gregory, Cyril Goudet
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 521-569
Open Access | Times Cited: 52
Group III Metabotropic Glutamate Receptors: Pharmacology, Physiology and Therapeutic Potential
Marion Mercier, David Lodge
Neurochemical Research (2014) Vol. 39, Iss. 10, pp. 1876-1894
Closed Access | Times Cited: 56
Regeneration in the nervous system with erythropoietin
Kenneth Maiese
Frontiers in bioscience (2015) Vol. 21, Iss. 3, pp. 561-596
Open Access | Times Cited: 51
Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies
Helena Domin, Łukasz Przykaza, Danuta Jantas, et al.
Neuropharmacology (2015) Vol. 102, pp. 276-294
Closed Access | Times Cited: 38
Group III metabotropic glutamate receptors as promising targets for neuroprotective therapy: Particular emphasis on the role of mGlu4 and mGlu7 receptors
Helena Domin
Pharmacology Biochemistry and Behavior (2022) Vol. 219, pp. 173452-173452
Closed Access | Times Cited: 14
Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death
Helena Domin, Danuta Jantas, Maria Śmiałowska
Neurochemistry International (2015) Vol. 88, pp. 110-123
Closed Access | Times Cited: 26
Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors
Yongjun Sun, Feng Xue, Yue Ding, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 24
Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation
Danuta Jantas, A. Gręda, Monika Leśkiewicz, et al.
Neurochemistry International (2015) Vol. 88, pp. 124-137
Closed Access | Times Cited: 22
Neuroprotective effect of the group III mGlu receptor agonist ACPT-I after ischemic stroke in rats with essential hypertension
Helena Domin, Łukasz Przykaza, Ewa Koźniewska, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 84, pp. 93-101
Closed Access | Times Cited: 20
Neurotransmitter receptors in Alzheimer's disease
Laura Lombardero, Alberto Llorente‐Ovejero, Iván Manuel, et al.
Elsevier eBooks (2020), pp. 441-456
Closed Access | Times Cited: 16
The antidepressant-like and glioprotective effects of the Y2 receptor antagonist SF-11 in the astroglial degeneration model of depression in rats: Involvement of glutamatergic inhibition
Helena Domin, Jolanta Konieczny, Paulina Cieślik, et al.
Behavioural Brain Research (2023) Vol. 457, pp. 114729-114729
Closed Access | Times Cited: 4
Group III metabotropic glutamate receptors: guardians against excitotoxicity in ischemic brain injury, with implications for neonatal contexts
Damian Mielecki, Elżbieta Salińska
Pharmacological Reports (2024)
Open Access | Times Cited: 1
mGlu4R, mGlu7R, and mGlu8R allosteric modulation for treating acute and chronic neurodegenerative disorders
Helena Domin, Grzegorz Burnat
Pharmacological Reports (2024)
Open Access | Times Cited: 1
The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage
Danuta Jantas, A. Gręda, Sławomir Gołda, et al.
Neuropharmacology (2016) Vol. 111, pp. 195-211
Closed Access | Times Cited: 10
Direct effects of the algal toxin, domoic acid, on ovarian function: Bovine granulosa and theca cells as an in vitro model
Fabiola Pizzo, F. Caloni, Nicole B. Schreiber, et al.
Ecotoxicology and Environmental Safety (2014) Vol. 113, pp. 314-320
Closed Access | Times Cited: 9
A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortex
Maria Śmiałowska, Barbara A. Zieba, Helena Domin
Neuropeptides (2021) Vol. 88, pp. 102162-102162
Closed Access | Times Cited: 7
Metabotropic glutamate receptors—guardians and gatekeepers in neonatal hypoxic-ischemic brain injury
Damian Mielecki, Ewelina Bratek-Gerej, Elżbieta Salińska
Pharmacological Reports (2024)
Open Access
Glutamate Receptors as Targets for Novel Antiepileptic Drug Therapy
Manola Cuéllar‐Herrera, Cesar Santana‐Gomez, Francia Carmona-Cruz, et al.
Methods in pharmacology and toxicology (2016), pp. 97-125
Closed Access | Times Cited: 1
Page 1

Scroll to top